BIOQUÍMICA Y BIOLOGÍA MOLECULAR
Department
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (31)
2024
-
Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition
Biochemical Pharmacology
-
Relationship between cholestasis and altered progesterone metabolism in the placenta-maternal liver tandem
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 2
2023
-
Impact of tumor suppressor genes inactivation on the multidrug resistance phenotype of hepatocellular carcinoma cells
Biomedicine and Pharmacotherapy, Vol. 165
2022
-
Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers
Cancers, Vol. 14, Núm. 14
-
Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems
Seminars in Liver Disease, Vol. 42, Núm. 1, pp. 087-103
-
Neuropilin-1 as a Potential Biomarker of Prognosis and Invasive-Related Parameters in Liver and Colorectal Cancer: A Systematic Review and Meta-Analysis of Human Studies
Cancers, Vol. 14, Núm. 14
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
P38γ and p38δ regulate postnatal cardiac metabolism through glycogen synthase 1
PLoS Biology, Vol. 19, Núm. 11
2020
-
Cellular mechanisms accounting for the refractoriness of colorectal carcinoma to pharmacological treatment
Cancers, Vol. 12, Núm. 9, pp. 1-34
-
Liver and gastrointestinal cancers
DRUG EFFLUX PUMPS IN CANCER RESISTANCE PATHWAYS: FROM MOLECULAR RECOGNITION AND CHARACTERIZATION TO POSSIBLE INHIBITION STRATEGIES IN CHEMOTHERAPY (ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD), pp. 197-250
-
Molecular bases of drug resistance in hepatocellular carcinoma
Cancers, Vol. 12, Núm. 6, pp. 1-26
-
Pilot multi-omic analysis of human bile from benign and malignant biliary strictures: A machine-learning approach
Cancers, Vol. 12, Núm. 6, pp. 1-30
-
Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1866, Núm. 5
2019
-
Unraveling ‘The Cancer Genome Atlas’ information on the role of SLC transporters in anticancer drug uptake
Expert Review of Clinical Pharmacology, Vol. 12, Núm. 4, pp. 329-341
-
What “The Cancer Genome Atlas” database tells us about the role of ATP-binding cassette (ABC) proteins in chemoresistance to anticancer drugs
Expert Opinion on Drug Metabolism and Toxicology, Vol. 15, Núm. 7, pp. 577-593
2018
-
Chemoresistance and chemosensitization in cholangiocarcinoma
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1444-1453
-
Genetic heterogeneity of SLC22 family of transporters in drug disposition
Journal of Personalized Medicine, Vol. 8, Núm. 2
-
Interaction of glucocorticoids with FXR/FGF19/FGF21-mediated ileum-liver crosstalk
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 9, pp. 2927-2937
-
Molecular bases of the poor response of liver cancer to chemotherapy
Clinics and Research in Hepatology and Gastroenterology
2017
-
Molecular bases of chemoresistance in cholangiocarcinoma
Current Drug Targets, Vol. 18, Núm. 8, pp. 889-900